Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin
Completed
Celerion
Phase 1
The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of
rosuvastatin and/or simvastatin in healthy male subjects and female subjects not of
child-bearing potential.
Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin
Completed
Madrigal Pharmaceuticals, Inc.
Phase 1
The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of
rosuvastatin and/or simvastatin in healthy male subjects and female subjects not of
child-bearing potential.
Drug Interaction Study of MGL-3196 With Atorvastatin
Completed
Celerion
Phase 1
The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of
atorvastatin in healthy male subjects and female subjects not of child-bearing potential.
Drug Interaction Study of MGL-3196 With Atorvastatin
Completed
Madrigal Pharmaceuticals, Inc.
Phase 1
The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of
atorvastatin in healthy male subjects and female subjects not of child-bearing potential.
Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Unknown status
Madrigal Pharmaceuticals, Inc.
Phase 2
The primary objective of this study is to determine the effect of once-daily oral MGL-3196 on
the percent change in hepatic fat fraction from baseline in patients with biopsy-proven
Non-alcoholic Steatohepatitis (NASH).
Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Completed
Madrigal Pharmaceuticals, Inc.
Phase 2
The primary objective of this study is to determine the effect of once-daily oral MGL-3196 on
the percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in patients
with Heterozygous Familial Hypercholesterolemia (HeFH).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
